The aim of this phase II prospective, randomized, open-labelled, dose ranging study is to evaluate the safety and efficacy of intermittently administered IV foscarnet for salvage therapy of active cytomegalovirus (CMV) retinitis in patients with AIDS.
Showing the most recent 10 out of 869 publications